Nephrology & Hypertension -
Topic: Nephrology Clinical Case Conference “Use of Gadolinium in CKD and ESRD patients”
Friday, May 27, 2022
12:00 PM - 1:00 PM
Osama Elhilali, M.D.
Fellow, Department of Medicine, Division of Nephrology and Hypertension
Upon completion of the presentation, participants will be able to:
1. Describe the properties of different formulations of Gadolinium
2. Discuss the potential toxicities of Gadolinium
3. Discuss available evidence for safety of Group 2 gadolinium in patients with CKD and the limitations of the evidence
4. Outline when hemodialysis may be necessary to prevent toxicity from Gadolinium and strategies which can be used
The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Florida College of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the Activity.
Osama Elhilali, M.D. has disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
For additional information, contact Casandra Caroccio (904) 244-5964 email@example.com.